Am J Psychiatry 1984; 141:1356-1364
Copyright © 1984 by American Psychiatric Association

REGULAR ARTICLES

A new rating scale for Alzheimer's disease

WG Rosen, RC Mohs and KL Davis

A new rating instrument, the Alzheimer's Disease Assessment Scale, was designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic of persons with Alzheimer's disease. Item descriptions, administration procedures, and scoring are outlined. Twenty-seven subjects with Alzheimer's disease and 28 normal elderly subjects were rated on 40 items. Twenty-one items with significant intraclass correlation coefficients for interrater reliability (range, .650-.989) and significant Spearman rank-order correlation coefficients for test-retest reliability (range, .514-1) constitute the final scale. Subjects with Alzheimer's disease had significantly more cognitive and noncognitive dysfunction than the normal elderly subjects.

This article has been cited by other articles:

				N. T. Lautenschlager, K. L. Cox, L. Flicker, J. K. Foster, F. M. van Bockxmeer, J. Xiao, K. R. Greenop, and O. P. Almeida Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease: A Randomized Trial JAMA, September 3, 2008; 300(9): 1027 - 1037. [Abstract] [Full Text] [PDF]

				T. Erkinjuntti, S. Gauthier, R. Bullock, A. Kurz, G. Hammond, S. Schwalen, Y. Zhu, and R. Brashear Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6) J Psychopharmacol, September 1, 2008; 22(7): 761 - 768. [Abstract] [PDF]

				S. M. Nestor, R. Rupsingh, M. Borrie, M. Smith, V. Accomazzi, J. L. Wells, J. Fogarty, R. Bartha, and the Alzheimer's Disease Neuroimaging Initiative Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database Brain, September 1, 2008; 131(9): 2443 - 2454. [Abstract] [Full Text] [PDF]

				R. Ferrucci, F. Mameli, I. Guidi, S. Mrakic-Sposta, M. Vergari, S. Marceglia, F. Cogiamanian, S. Barbieri, E. Scarpini, and A. Priori Transcranial direct current stimulation improves recognition memory in Alzheimer disease Neurology, August 12, 2008; 71(7): 493 - 498. [Abstract] [Full Text] [PDF]

				B Miranda, S Madureira, A Verdelho, J Ferro, L Pantoni, E Salvadori, H Chabriat, T Erkinjuntti, F Fazekas, M Hennerici, et al. Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 869 - 873. [Abstract] [Full Text] [PDF]

				J. J. Jalbert, L. A. Daiello, and K. L. Lapane Dementia of the Alzheimer Type Epidemiol. Rev., July 16, 2008; (2008) mxn008v1. [Abstract] [Full Text] [PDF]

				D. L. Sultzer, S. M. Davis, P. N. Tariot, K. S. Dagerman, B. D. Lebowitz, C. G. Lyketsos, R. A. Rosenheck, J. K. Hsiao, J. A. Lieberman, L. S. Schneider, et al. Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer's Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial Am J Psychiatry, July 1, 2008; 165(7): 844 - 854. [Abstract] [Full Text] [PDF]

				P. J. Modrego, I. Monleon, and M. Sarasa The Clinical Significance of Plasmatic Amyloid A{beta}-40 Peptide Levels in Alzheimer's Disease Patients Treated With Galantamine American Journal of Alzheimer's Disease and Other Dementias, June 1, 2008; 23(3): 286 - 290. [Abstract] [PDF]

				B. Winblad, S. Gauthier, L. Scinto, H. Feldman, G. K. Wilcock, L. Truyen, A. J. Mayorga, D. Wang, H. R. Brashear, J. S. Nye, et al. Safety and efficacy of galantamine in subjects with mild cognitive impairment Neurology, May 27, 2008; 70(22): 2024 - 2035. [Abstract] [Full Text] [PDF]

				M Suenaga, Y Kawai, H Watanabe, N Atsuta, M Ito, F Tanaka, M Katsuno, H Fukatsu, S Naganawa, and G Sobue Cognitive impairment in spinocerebellar ataxia type 6 J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 496 - 499. [Abstract] [Full Text] [PDF]

				P. Raina, P. Santaguida, A. Ismaila, C. Patterson, D. Cowan, M. Levine, L. Booker, and M. Oremus Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline Ann Intern Med, March 4, 2008; 148(5): 379 - 397. [Abstract] [Full Text] [PDF]

				P. J. Modrego, C. Rios, J. M. Perez Trullen, J. M. Errea, M. J. Garcia-Gomara, and S. Sanchez The Cerebrovascular Pathology in Alzheimer's Disease and Its Influence on Clinical Variables American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 91 - 96. [Abstract] [PDF]

				J Warner, R McCarney, M Griffin, K Hill, and P Fisher Participation in dementia research: rates and correlates of capacity to give informed consent J. Med. Ethics, March 1, 2008; 34(3): 167 - 170. [Abstract] [Full Text] [PDF]

				L. Bonanni, A. Thomas, P. Tiraboschi, B. Perfetti, S. Varanese, and M. Onofrj EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up Brain, March 1, 2008; 131(3): 690 - 705. [Abstract] [Full Text] [PDF]

				A. S. Fleisher, S. Sun, C. Taylor, C. P. Ward, A. C. Gamst, R. C. Petersen, C. R. Jack Jr, P. S. Aisen, L. J. Thal, and For the Alzheimer's Disease Cooperative Study Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment Neurology, January 15, 2008; 70(3): 191 - 199. [Abstract] [Full Text] [PDF]

				D. E. Alley, E. M. Crimmins, A. Karlamangla, P. Hu, and T. E. Seeman Inflammation and Rate of Cognitive Change in High-Functioning Older Adults J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2008; 63(1): 50 - 55. [Abstract] [Full Text] [PDF]

				J. Wancata, A. Borjesson-Hanson, S. Ostling, K. Sjogren, and I. Skoog Diagnostic Criteria Influence Dementia Prevalence Am J Geriatr Psychiatry, December 1, 2007; 15(12): 1034 - 1045. [Abstract] [Full Text] [PDF]

				B. C. Dickerson, R. A. Sperling, B. T. Hyman, M. S. Albert, and D. Blacker Clinical Prediction of Alzheimer Disease Dementia Across the Spectrum of Mild Cognitive Impairment Arch Gen Psychiatry, December 1, 2007; 64(12): 1443 - 1450. [Abstract] [Full Text] [PDF]

				A. J. Bastos-Leite, W. M. van der Flier, E. C.W. van Straaten, S. S. Staekenborg, P. Scheltens, and F. Barkhof The Contribution of Medial Temporal Lobe Atrophy and Vascular Pathology to Cognitive Impairment in Vascular Dementia Stroke, December 1, 2007; 38(12): 3182 - 3185. [Abstract] [Full Text] [PDF]

				S. L. Tyas, D. A. Snowdon, M. F. Desrosiers, K. P. Riley, and W. R. Markesbery Healthy ageing in the Nun Study: definition and neuropathologic correlates Age Ageing, November 1, 2007; 36(6): 650 - 655. [Abstract] [Full Text] [PDF]

				L. A. van de Pol, W. M. van der Flier, E.S.C. Korf, N. C. Fox, F. Barkhof, and P. Scheltens Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment Neurology, October 9, 2007; 69(15): 1491 - 1497. [Abstract] [Full Text] [PDF]

				K. Bronnick, M. Emre, R. Lane, S. Tekin, and D. Aarsland Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1064 - 1068. [Abstract] [Full Text] [PDF]

				H. H Feldman, R. Lane, and on behalf of the Study 304 Group Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1056 - 1063. [Abstract] [Full Text] [PDF]

				G. Allen, H. Barnard, R. McColl, A. L. Hester, J. A. Fields, M. F. Weiner, W. K. Ringe, A. M. Lipton, M. Brooker, E. McDonald, et al. Reduced Hippocampal Functional Connectivity in Alzheimer Disease Arch Neurol, October 1, 2007; 64(10): 1482 - 1487. [Abstract] [Full Text] [PDF]

				Y.-F. Y. Lu, M. G. Austrom, S. M. Perkins, T. Bakas, M. R. Farlow, Feng He, Shelia Jin, and A. Gamst Depressed Mood in Informal Caregivers of Individuals With Mild Cognitive Impairment American Journal of Alzheimer's Disease and Other Dementias, September 1, 2007; 22(4): 273 - 285. [Abstract] [PDF]

				R. Gregory, F. Roked, L. Jones, and A. Patel Is the degree of cognitive impairment in patients with Alzheimer's disease related to their capacity to appoint an enduring power of attorney? Age Ageing, September 1, 2007; 36(5): 527 - 531. [Abstract] [Full Text] [PDF]

				A. P. Auchus, H. R. Brashear, S. Salloway, A. D. Korczyn, P. P. De Deyn, C. Gassmann-Mayer, and For the GAL-INT-26 Study Group Galantamine treatment of vascular dementia: A randomized trial Neurology, July 31, 2007; 69(5): 448 - 458. [Abstract] [Full Text] [PDF]

				B. Winblad, G. Grossberg, L. Frolich, M. Farlow, S. Zechner, J. Nagel, and R. Lane IDEAL: A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease Neurology, July 24, 2007; 69(4_suppl_1): S14 - S22. [Abstract] [Full Text] [PDF]

				L. A. van de Pol, E. S. C. Korf, W. M. van der Flier, H. R. Brashear, N. C. Fox, F. Barkhof, and P. Scheltens Magnetic Resonance Imaging Predictors of Cognition in Mild Cognitive Impairment Arch Neurol, July 1, 2007; 64(7): 1023 - 1028. [Abstract] [Full Text] [PDF]

				V. Gelfanova, R. E. Higgs, R. A. Dean, D. M. Holtzman, M. R. Farlow, E. R. Siemers, A. Boodhoo, Y.-W. Qian, X. He, Z. Jin, et al. Quantitative analysis of amyloid-{beta} peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry Brief Funct Genomic Proteomic, June 20, 2007; (2007) elm010v1. [Abstract] [Full Text] [PDF]

				A. S. Fleisher, B. B. Sowell, C. Taylor, A. C. Gamst, R. C. Petersen, L. J. Thal, and for the Alzheimer's Disease Cooperative Study Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment Neurology, May 8, 2007; 68(19): 1588 - 1595. [Abstract] [Full Text] [PDF]

				J. Chodosh, D. M. Kado, T. E. Seeman, and A. S. Karlamangla Depressive Symptoms as a Predictor of Cognitive Decline: MacArthur Studies of Successful Aging Am J Geriatr Psychiatry, May 1, 2007; 15(5): 406 - 415. [Abstract] [Full Text] [PDF]

				K. Rockwood, S. Fay, P. Jarrett, and E. Asp Effect of galantamine on verbal repetition in AD: A secondary analysis of the VISTA trial Neurology, April 3, 2007; 68(14): 1116 - 1121. [Abstract] [Full Text] [PDF]

				P. Edison, H. A. Archer, R. Hinz, A. Hammers, N. Pavese, Y. F. Tai, G. Hotton, D. Cutler, N. Fox, A. Kennedy, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study Neurology, February 13, 2007; 68(7): 501 - 508. [Abstract] [Full Text] [PDF]

				A. T. Blaszczyk and M. Mathys Treatment of Cognitive Decline and Psychiatric Disturbances Associated With Alzheimer's Dementia Journal of Pharmacy Practice, February 1, 2007; 20(1): 13 - 28. [Abstract] [PDF]

				E. M. Balk, G. Raman, A. Tatsioni, M. Chung, J. Lau, and I. H. Rosenberg Vitamin B6, B12, and Folic Acid Supplementation and Cognitive Function: A Systematic Review of Randomized Trials Arch Intern Med, January 8, 2007; 167(1): 21 - 30. [Abstract] [Full Text] [PDF]

				D. Inzitari, M. Simoni, G. Pracucci, A. Poggesi, A. M. Basile, H. Chabriat, T. Erkinjuntti, F. Fazekas, J. M. Ferro, M. Hennerici, et al. Risk of Rapid Global Functional Decline in Elderly Patients With Severe Cerebral Age-Related White Matter Changes: The LADIS Study Arch Intern Med, January 8, 2007; 167(1): 81 - 88. [Abstract] [Full Text] [PDF]

				G Livingston, A E Walker, C L E Katona, and C Cooper Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 25 - 29. [Abstract] [Full Text] [PDF]

				Y. Nagahama, T. Okina, N. Suzuki, and M. Matsuda The cambridge behavioral inventory: validation and application in a memory clinic. J Geriatr Psychiatry Neurol, December 1, 2006; 19(4): 220 - 225. [Abstract] [PDF]

				F. Chiappelli, A. M. Navarro, D. R. Moradi, E. Manfrini, and P. Prolo Evidence-Based Research in Complementary and Alternative Medicine III: Treatment of Patients with Alzheimer's Disease Evid. Based Complement. Altern. Med., December 1, 2006; 3(4): 411 - 424. [Abstract] [Full Text] [PDF]

				H. H. Dodge, Y. Du, J. A. Saxton, and M. Ganguli Cognitive Domains and Trajectories of Functional Independence in Nondemented Elderly Persons J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1330 - 1337. [Abstract] [Full Text] [PDF]

				P. S. Aisen, D. Saumier, R. Briand, J. Laurin, F. Gervais, P. Tremblay, and D. Garceau A Phase II study targeting amyloid-{beta} with 3APS in mild-to-moderate Alzheimer disease Neurology, November 28, 2006; 67(10): 1757 - 1763. [Abstract] [Full Text] [PDF]

				K Bronnick, U Ehrt, M Emre, P P De Deyn, K Wesnes, S Tekin, and D Aarsland Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1136 - 1142. [Abstract] [Full Text] [PDF]

				L Tarraga, M Boada, G Modinos, A Espinosa, S Diego, A Morera, M Guitart, J Balcells, O L Lopez, and J T Becker A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1116 - 1121. [Abstract] [Full Text] [PDF]

				M. Tsolaki, A. Alexiadou, G. Kiosseoglou, and F. Kounti Correlations between the Functional-Cognitive Assessment Scale and the Alzheimer's Disease Assessment Scale when administered to patients with dementia residing in long-term care. American Journal of Alzheimer's Disease and Other Dementias, August 1, 2006; 21(4): 274 - 280. [Abstract] [PDF]

				E. R. Peskind, S. G. Potkin, N. Pomara, B. R. Ott, S. M. Graham, J. T. Olin, S. McDonald, and for the Memantine MEM-MD-10 Study Group Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial Am J Geriatr Psychiatry, August 1, 2006; 14(8): 704 - 715. [Abstract] [Full Text] [PDF]

				J. L. Cummings, T. McRae, R. Zhang, and The Donepezil-Sertraline Study Group Effects of Donepezil on Neuropsychiatric Symptoms in Patients With Dementia and Severe Behavioral Disorders Am J Geriatr Psychiatry, July 1, 2006; 14(7): 605 - 612. [Abstract] [Full Text] [PDF]

				M. KNAPP, L. THORGRIMSEN, A. PATEL, A. SPECTOR, A. HALLAM, B. WOODS, and M. ORRELL Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis The British Journal of Psychiatry, June 1, 2006; 188(6): 574 - 580. [Abstract] [Full Text] [PDF]

				K. Rockwood, S. Fay, X. Song, C. MacKnight, M. Gorman, and on behalf of the Video-Imaging Synthesis of Treati Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial Can. Med. Assoc. J., April 11, 2006; 174(8): 1099 - 1105. [Abstract] [Full Text] [PDF]

				M. Ganguli, Y. Du, H. H. Dodge, G. G. Ratcliff, and C.-C. H. Chang Depressive Symptoms and Cognitive Decline in Late Life: A Prospective Epidemiological Study Arch Gen Psychiatry, February 1, 2006; 63(2): 153 - 160. [Abstract] [Full Text] [PDF]

				P. H. Lu, D. A. Masterman, R. Mulnard, C. Cotman, B. Miller, K. Yaffe, E. Reback, V. Porter, R. Swerdloff, and J. L. Cummings Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men Arch Neurol, February 1, 2006; 63(2): 177 - 185. [Abstract] [Full Text] [PDF]

				A. J. Bastos Leite, W. M. van der Flier, E. C. W. van Straaten, P. Scheltens, and F. Barkhof Infratentorial Abnormalities in Vascular Dementia Stroke, January 1, 2006; 37(1): 105 - 110. [Abstract] [Full Text] [PDF]

				S. Sacuiu, M. Sjogren, B. Johansson, D. Gustafson, and I. Skoog Prodromal cognitive signs of dementia in 85-year-olds using four sources of information Neurology, December 27, 2005; 65(12): 1894 - 1900. [Abstract] [Full Text] [PDF]

				R Overshott and A Burns Treatment of dementia J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(suppl_5): v53 - v59. [Full Text] [PDF]